Tratamientos potenciados de la migraña basados en miméticos de grelina
Anamorelina o una sal farmacéuticamente aceptable de la misma para su uso en el tratamiento de la migraña en un sujeto, administrándose a dicho sujeto un agonista del receptor de serotonina 5-HT1B/1D seleccionado de sumatriptán o una sal farmacéuticamente aceptable del mismo..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Europäisches Patentamt - (2016) vom: 08. Feb. Zur Gesamtaufnahme - year:2016 |
|---|
| Sprache: |
Spanisch |
|---|
| Beteiligte Personen: |
POLVINO WILLIAM J [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2016-02-08, Last update posted on www.tib.eu: 2022-09-04, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
ES2558701 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA013400770 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA013400770 | ||
| 003 | DE-627 | ||
| 005 | 20230504100414.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2016 xx |||||o 00| ||spa c | ||
| 035 | |a (DE-627)EPA013400770 | ||
| 035 | |a (EPA)ES2558701 | ||
| 035 | |a (EPA)42144981 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 0 | |a POLVINO WILLIAM J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tratamientos potenciados de la migraña basados en miméticos de grelina |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2016-02-08, Last update posted on www.tib.eu: 2022-09-04, Last updated: 2023-02-09 | ||
| 520 | |a Anamorelina o una sal farmacéuticamente aceptable de la misma para su uso en el tratamiento de la migraña en un sujeto, administrándose a dicho sujeto un agonista del receptor de serotonina 5-HT1B/1D seleccionado de sumatriptán o una sal farmacéuticamente aceptable del mismo. | ||
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2016) vom: 08. Feb. |
| 773 | 1 | 8 | |g year:2016 |g day:08 |g month:02 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/42144981/publication/ES2558701A1?q=ES2558701 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2016 |b 08 |c 02 |
| 951 | |a AR | ||
| 952 | |j 2016 |b 08 |c 02 | ||